Ligand · UCG
UCG · 3'-O-[(R)-{[(2R,3aR,4R,6R,6aR)-6-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-hydroxy-2-oxidotetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl]methoxy}(hydroxy)phosphoryl]uridine 5'-(dihydrogen phosphate)
UCG, 3'-O-[(R)-{[(2R,3aR,4R,6R,6aR)-6-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-hydroxy-2-oxidotetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl]methoxy}(hydroxy)phosphoryl]uridine 5'-(dihydrogen phosphate) (C19 H24 N7 O18 P3, 731.4 g/mol)…
- Component
- UCG
- Formula
- C19 H24 N7 O18 P3
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
UCG in 4 structures; the first of them:
- 4R07 · Crystal structure of human TLR8 in complex with ORN06 · UCG A902 · binds TYR291, LYS314, VAL315, GLU340, ILE341, ASP343, SER345, ARG370 and 10 more
- 4R08 · Crystal structure of human TLR8 in complex with ssRNA40 · UCG A915 · binds TYR291, LYS314, VAL315, GLU340, ILE341, ASP343, SER345, ARG370 and 10 more
- 4R07 · Crystal structure of human TLR8 in complex with ORN06 · UCG A902 · binds TYR291, LYS314, VAL315, GLU340, ILE341, ASP343, SER345, ARG370 and 10 more
- 4R08 · Crystal structure of human TLR8 in complex with SSRNA40 · UCG A915 · binds TYR291, LYS314, VAL315, GLU340, ILE341, ASP343, SER345, ARG370 and 10 more
Residues it binds most
ARG 16, HIS 16, ASN 16, GLU 16, ASP 16, THR 16, ILE 16, LEU 16, LYS 16, PHE 16 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.